244 related articles for article (PubMed ID: 26974204)
21. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
Gong K; Zhang N; Zhang K; Na Y
Int J Mol Med; 2010 Dec; 26(6):907-12. PubMed ID: 21042786
[TBL] [Abstract][Full Text] [Related]
22. Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells.
Ader I; Brizuela L; Bouquerel P; Malavaud B; Cuvillier O
Cancer Res; 2008 Oct; 68(20):8635-42. PubMed ID: 18922940
[TBL] [Abstract][Full Text] [Related]
23. Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters.
Gomez-Brouchet A; Illac C; Ledoux A; Fortin PY; de Barros S; Vabre C; Despas F; Peries S; Casaroli C; Bouvier C; Aubert S; de Pinieux G; Larousserie F; Galmiche L; Talmont F; Pitson S; Maddelein ML; Cuvillier O
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158767
[TBL] [Abstract][Full Text] [Related]
24. Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells.
Cho SY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Chen CY; Lee EO; Kim SH
J Pineal Res; 2011 Aug; 51(1):87-93. PubMed ID: 21392092
[TBL] [Abstract][Full Text] [Related]
25. Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer.
Ader I; Gstalder C; Bouquerel P; Golzio M; Andrieu G; Zalvidea S; Richard S; Sabbadini RA; Malavaud B; Cuvillier O
Oncotarget; 2015 May; 6(15):13803-21. PubMed ID: 25915662
[TBL] [Abstract][Full Text] [Related]
26. Ascorbate modulates the hypoxic pathway by increasing intracellular activity of the HIF hydroxylases in renal cell carcinoma cells.
Wohlrab C; Kuiper C; Vissers MC; Phillips E; Robinson BA; Dachs GU
Hypoxia (Auckl); 2019; 7():17-31. PubMed ID: 31192266
[No Abstract] [Full Text] [Related]
27. OGT/HIF-2α axis promotes the progression of clear cell renal cell carcinoma and regulates its sensitivity to ferroptosis.
Yang Z; Wei X; Ji C; Ren X; Su W; Wang Y; Zhou J; Zhao Z; Zhou P; Zhao K; Yao B; Song N; Qin C
iScience; 2023 Nov; 26(11):108148. PubMed ID: 37915611
[TBL] [Abstract][Full Text] [Related]
28. Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha.
Shinojima T; Oya M; Takayanagi A; Mizuno R; Shimizu N; Murai M
Carcinogenesis; 2007 Mar; 28(3):529-36. PubMed ID: 16920734
[TBL] [Abstract][Full Text] [Related]
29. HIF-2α-induced upregulation of CD36 promotes the development of ccRCC.
Liao M; Li Y; Xiao A; Lu Q; Zeng H; Qin H; Zheng E; Luo X; Chen L; Ruan XZ; Yang P; Chen Y
Exp Cell Res; 2022 Dec; 421(2):113389. PubMed ID: 36252650
[TBL] [Abstract][Full Text] [Related]
30. Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α.
Fan Y; Li H; Ma X; Gao Y; Bao X; Du Q; Ma M; Liu K; Yao Y; Huang Q; Zhang Y; Zhang X
Oncotarget; 2016 Apr; 7(14):18280-94. PubMed ID: 26943772
[TBL] [Abstract][Full Text] [Related]
31. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM
PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555
[TBL] [Abstract][Full Text] [Related]
32.
Ren X; Diao X; Zhuang J; Wu D
Mol Pharmacol; 2022 Sep; ():. PubMed ID: 36167425
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic Acinar Cells-Derived Sphingosine-1-Phosphate Contributes to Fibrosis of Chronic Pancreatitis via Inducing Autophagy and Activation of Pancreatic Stellate Cells.
Wang D; Han S; Lv G; Hu Y; Zhuo W; Zeng Z; Tang J; Huang Y; Wang F; Wang J; Zhao Y; Zhao G
Gastroenterology; 2023 Dec; 165(6):1488-1504.e20. PubMed ID: 37634735
[TBL] [Abstract][Full Text] [Related]
34. E2F3 upregulation promotes tumor malignancy through the transcriptional activation of HIF-2α in clear cell renal cell carcinoma.
Gao Y; Li H; Ma X; Fan Y; Ni D; Zhang Y; Huang Q; Liu K; Li X; Wang L; Yao Y; Ai Q; Zhang X
Oncotarget; 2017 Aug; 8(33):54021-54036. PubMed ID: 28903320
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-Inducible Factor-2α as a Novel Target in Renal Cell Carcinoma.
Choi WSW; Boland J; Lin J
J Kidney Cancer VHL; 2021; 8(2):1-7. PubMed ID: 33868900
[TBL] [Abstract][Full Text] [Related]
36. The uremic toxin p-cresyl sulfate induces proliferation and migration of clear cell renal cell carcinoma via microRNA-21/ HIF-1α axis signals.
Wu TK; Wei CW; Pan YR; Hsu RJ; Wu CY; Yu YL
Sci Rep; 2019 Mar; 9(1):3207. PubMed ID: 30824757
[TBL] [Abstract][Full Text] [Related]
37. [Expression of hypoxia-inducible factor-1-alpha, hypoxia-inducible factor-2alpha and vascular endothelial growth factor in sporadic clear cell renal cell renal cell carcinoma and their significance in the pathogenesis thereof].
Zhang N; Gong K; Yang XY; Xin DQ; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(22):1526-9. PubMed ID: 16854277
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.
Zhai W; Sun Y; Jiang M; Wang M; Gasiewicz TA; Zheng J; Chang C
Oncogene; 2016 Sep; 35(37):4866-80. PubMed ID: 26973243
[TBL] [Abstract][Full Text] [Related]
39. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
[TBL] [Abstract][Full Text] [Related]
40. HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma.
Maroto P; Esteban E; Parra EF; Mendez-Vidal MJ; Domenech M; Pérez-Valderrama B; Calderero V; Pérez-Gracia JL; Grande E; Algaba F
Onco Targets Ther; 2017; 10():4635-4643. PubMed ID: 29033582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
